Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
出版年份 2019 全文链接
标题
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
作者
关键词
-
出版物
Cancers
Volume 11, Issue 9, Pages 1284
出版商
MDPI AG
发表日期
2019-09-02
DOI
10.3390/cancers11091284
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells
- (2019) So Jung Sung et al. Biomolecules & Therapeutics
- c-MYB and DMTF1 in Cancer
- (2019) Elizabeth A. Fry et al. CANCER INVESTIGATION
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Mebendazole induces apoptosis via C-MYC inactivation in malignant ascites cell line (AGP01)
- (2019) Laine Celestino Pinto et al. TOXICOLOGY IN VITRO
- Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing
- (2018) Jenny Rubin et al. Oncotarget
- Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines
- (2018) Vera Kralova et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Mebendazole potentiates radiation therapy in triple-negative breast cancer
- (2018) Le Zhang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma
- (2018) Christine G. Skibinski et al. JOURNAL OF NEURO-ONCOLOGY
- Chemoresistance and the Self-Maintaining Tumor Microenvironment
- (2018) Gulcen Yeldag et al. Cancers
- The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation
- (2017) Kristin Blom et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas
- (2017) Franciele Cristina Kipper et al. INVESTIGATIONAL NEW DRUGS
- Targeting acute myeloid leukemia by drug-induced c-MYB degradation
- (2017) V Walf-Vorderwülbecke et al. LEUKEMIA
- Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors
- (2017) Michelle De Witt et al. MOLECULAR MEDICINE
- Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis
- (2017) Laine Celestino Pinto et al. TOXICOLOGY IN VITRO
- Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism
- (2017) Daniel Markowitz et al. OncoTargets and Therapy
- The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma
- (2017) Cynthia M. Simbulan-Rosenthal et al. Oncotarget
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- Tumor microenvironment-mediated chemoresistance in breast cancer
- (2016) Kobra velaei et al. BREAST
- Analysis of mebendazole binding to its target biomolecule by laser flash photolysis
- (2016) Dolors Jornet et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Management of Atypical and Anaplastic Meningiomas
- (2016) Simon Buttrick et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer
- (2016) Ruth J. Davis et al. ORAL ONCOLOGY
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
- (2016) Tara Williamson et al. Oncotarget
- DNA Damage Response Is Involved in the Developmental Toxicity of Mebendazole in Zebrafish Retina
- (2016) Shota Sasagawa et al. Frontiers in Pharmacology
- Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor
- (2016) Zhi Tan et al. Scientific Reports
- Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model
- (2015) R.-Y. Bai et al. CLINICAL CANCER RESEARCH
- RepurposeVS: A Drug Repurposing-Focused Computational Method for Accurate Drug-Target Signature Predictions
- (2015) Naiem Issa et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism
- (2015) Helena Joyce et al. Expert Opinion on Drug Metabolism & Toxicology
- Drug repurposing in oncology—patient and health systems opportunities
- (2015) Francesco Bertolini et al. Nature Reviews Clinical Oncology
- Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
- (2015) Marianne S. Poruchynsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model
- (2015) Laine Celestino Pinto et al. TOXICOLOGY IN VITRO
- Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor
- (2014) A. R. Larsen et al. MOLECULAR CANCER THERAPEUTICS
- Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis
- (2014) Ren-Yuan Bai et al. NEURO-ONCOLOGY
- Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer
- (2013) Peter Nygren et al. ACTA ONCOLOGICA
- Low-dose metronomic chemotherapy: A systematic literature analysis
- (2013) K. Lien et al. EUROPEAN JOURNAL OF CANCER
- Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
- (2013) Peter Nygren et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Unraveling the therapeutic potential of the Hedgehog pathway in cancer
- (2013) Dereck Amakye et al. NATURE MEDICINE
- Targeting cancer stem cells to suppress acquired chemotherapy resistance
- (2013) S J Vidal et al. ONCOGENE
- XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts
- (2012) Nicole A. Doudican et al. ANTI-CANCER DRUGS
- Predicting New Indications for Approved Drugs Using a Proteochemometric Method
- (2012) Sivanesan Dakshanamurthy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma
- (2011) Irina Dobrosotskaya et al. Endocrine Practice
- Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
- (2011) Ren-Yuan Bai et al. NEURO-ONCOLOGY
- Targeting X-Linked Inhibitor of Apoptosis Protein to Increase the Efficacy of Endoplasmic Reticulum Stress-Induced Apoptosis for Melanoma Therapy
- (2010) Emma L. Hiscutt et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
- (2009) Mohammad H. Pourgholami et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers
- (2009) Natascia Corti et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Targeting protein kinases in central nervous system disorders
- (2009) Laura K. Chico et al. NATURE REVIEWS DRUG DISCOVERY
- Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells
- (2008) N. Doudican et al. MOLECULAR CANCER RESEARCH
- Albendazole as an adjuvant to the standard surgical management of hydatid cyst liver
- (2008) Sajad Hussain Arif et al. International Journal of Surgery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now